Page last updated: 2024-10-23

bepridil and Experimental Lung Inflammation

bepridil has been researched along with Experimental Lung Inflammation in 1 studies

Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.

Experimental Lung Inflammation: Inflammation of any part, segment or lobe, of the lung parenchyma.

Research Excerpts

ExcerptRelevanceReference
"A 66-year-old man had been given bepridil for the treatment of atrial fibrillation since April 28, 2002."3.73[A case of drug-induced pneumonitis due to bepridil]. ( Ando, M; Ashihara, Y; Fukami, T; Ito, T; Kumamoto, T; Matsuno, O; Miyazaki, E; Nishitake, T; Okubo, F; Okubo, T, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Okubo, F1
Ando, M1
Ashihara, Y1
Okubo, T1
Nishitake, T1
Ito, T1
Matsuno, O1
Fukami, T1
Miyazaki, E1
Kumamoto, T1

Other Studies

1 other study available for bepridil and Experimental Lung Inflammation

ArticleYear
[A case of drug-induced pneumonitis due to bepridil].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2006, Volume: 44, Issue:1

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Humans; Male; Pneumonia

2006